Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses-Reference-Cited by-同舟云学术

Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

Published:2013-11 Issue:2 Volume:269 Page:603-611
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Choi Gwang Hyeon,Shim Ju Hyun,Kim Min-Joo,Ryu Min-Hee,Ryoo Baek-Yeol,Kang Yoon-Koo,Shin Yong Moon,Kim Kang Mo,Lim Young-Suk,Lee Han Chu

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.13130150

Reference33 articles.

1. Management of hepatocellular carcinoma: An update

2. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus–endemic area

3. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

4. Sorafenib in Advanced Hepatocellular Carcinoma

5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridge Therapy before Liver Transplant for Advanced Hepatocellular Carcinoma;Medicina;2024-06-20

2. A Retrospective Cohort Analysis of Transarterial Chemoembolization for Hepatocellular Cancer at a Tertiary Center in Switzerland;Journal of Clinical Medicine;2024-06-02

3. Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus;JAMA Surgery;2024-06-01

4. A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways;Medical Oncology;2024-05-04

5. Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study;Frontiers in Immunology;2023-11-27